Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

SNY - Sanofi - ADR


IEX Last Trade
56.245
-0.085   -0.151%

Share volume: 1,669,666
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$56.33
-0.09
-0.15%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0.09%
1 Month
8.84%
3 Months
17.62%
6 Months
22.18%
1 Year
8.32%
2 Year
47.55%
Key data
Stock price
$56.24
P/E Ratio 
23.91
DAY RANGE
N/A - N/A
EPS 
$2.38
52 WEEK RANGE
$40.90 - $56.57
52 WEEK CHANGE
$0.10
MARKET CAP 
142.744 B
YIELD 
3.62%
SHARES OUTSTANDING 
2.537 B
DIVIDEND
$2.0369
EX-DIVIDEND DATE
05/09/2024
NEXT EARNINGS DATE
10/25/2024
BETA 
0.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,350,952
AVERAGE 30 VOLUME 
$1,536,127
Company detail
CEO: Paul Hudson
Region: US
Website: https://www.sanofi.com/
Employees: 91,573
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo

Recent news